John Hardy

Molecular Biology · 2000–2021

A researcher in the Science corpus: 45 papers; trusts 9 researchers and is trusted by 27 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 384 citations into it; #5,605 of 17,773 by trust here, #929 by citations
• Physiology — 323 citations into it; #159 of 2,276 by trust here, #18 by citations
• Neurology — 171 citations into it; #462 of 1,455 by trust here, #10 by citations
• Psychiatry and Mental health — 123 citations into it; #911 of 1,338 by trust here, #312 by citations
• Cognitive Neuroscience — 55 citations into it
• Computational Theory and Mathematics — 30 citations into it; #5,455 of 12,182 by trust here, #1,269 by citations
• Developmental Neuroscience — 14 citations into it
• Biological Psychiatry — 8 citations into it; #127 of 200 by trust here, #75 by citations

Whom John Hardy trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. H. Braak
2. D. Selkoe
3. D. Diamond
4. S. Oddo
5. D. Thal
6. Raphael Kopan
7. D. Holtzman
8. C. Holmes
9. Clifford R. Jack Jr.
10. B. Omalu

Who trusts John Hardy overall

1. Jeffrey J. Iliff
2. Barbara E. Stranger
3. Teri Manolio
4. Eric E. Schadt
5. Hedok Lee
6. Eli A. Stahl
7. Wei-Wei Chen
8. Tamer A E Ahmed
9. Berislav Zlokovic
10. Clifford R. Jack Jr.

Papers from John Hardy's perspective

Ordered by how strongly the researchers John Hardy trusts endorse each paper. Same corpus, a different order for every researcher.

1. Neuropathological stageing of Alzheimer-related changes
2. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (Science)
3. The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set (Alzheimer Disease and Associated Disorders)
4. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function (Science)
5. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques (Proceedings of the National Academy of Sciences of the United States of America)
6. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration (Acta Neuropathologica)
7. ApoE promotes the proteolytic degradation of Abeta. (Neuron)
8. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics (Science)
9. Alzheimer disease in the US population: prevalence estimates using the 2000 census. (Archives of Neurology)
10. Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)

Their papers

• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease (2013) — 4,257 citations
• The transcriptional landscape of age in human peripheral blood (2015) — 654 citations
• Common genetic variants influence human subcortical brain structures (2015) — 868 citations
• Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP (2001) — 1,666 citations
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
• CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation (2004) — 740 citations
• Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease (2000) — 1,404 citations
• Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein (2000) — 1,320 citations
• Genetic variability in the regulation of gene expression in ten regions of the human brain (2014) — 686 citations
• The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal (2009) — 842 citations
• Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives (2010) — 659 citations
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) — 1,794 citations
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease (2009) — 1,585 citations
• Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
• Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk (2019) — 2,006 citations
• The Amyloid-β Pathway in Alzheimer’s Disease (2021) — 1,619 citations
• Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-genome wide association study (2019) — 1,651 citations
• Alzheimer's disease (2018) — 1,865 citations
• APP mouse models for Alzheimer's disease preclinical studies (2017) — 674 citations
• Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences (2016) — 640 citations